1. Home
  2. TMDX vs SPR Comparison

TMDX vs SPR Comparison

Compare TMDX & SPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • SPR
  • Stock Information
  • Founded
  • TMDX 1998
  • SPR 1927
  • Country
  • TMDX United States
  • SPR United States
  • Employees
  • TMDX N/A
  • SPR N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SPR Military/Government/Technical
  • Sector
  • TMDX Health Care
  • SPR Industrials
  • Exchange
  • TMDX Nasdaq
  • SPR Nasdaq
  • Market Cap
  • TMDX 4.8B
  • SPR 4.7B
  • IPO Year
  • TMDX 2019
  • SPR 2006
  • Fundamental
  • Price
  • TMDX $122.68
  • SPR $39.74
  • Analyst Decision
  • TMDX Buy
  • SPR Hold
  • Analyst Count
  • TMDX 9
  • SPR 2
  • Target Price
  • TMDX $123.00
  • SPR $38.63
  • AVG Volume (30 Days)
  • TMDX 1.3M
  • SPR 713.6K
  • Earning Date
  • TMDX 07-30-2025
  • SPR 08-05-2025
  • Dividend Yield
  • TMDX N/A
  • SPR N/A
  • EPS Growth
  • TMDX 2163.11
  • SPR N/A
  • EPS
  • TMDX 2.02
  • SPR N/A
  • Revenue
  • TMDX $531,292,000.00
  • SPR $6,278,800,000.00
  • Revenue This Year
  • TMDX $34.57
  • SPR $24.21
  • Revenue Next Year
  • TMDX $20.83
  • SPR $14.89
  • P/E Ratio
  • TMDX $61.12
  • SPR N/A
  • Revenue Growth
  • TMDX 48.09
  • SPR N/A
  • 52 Week Low
  • TMDX $55.00
  • SPR $27.00
  • 52 Week High
  • TMDX $177.37
  • SPR $42.33
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 51.30
  • SPR 47.79
  • Support Level
  • TMDX $114.30
  • SPR $39.50
  • Resistance Level
  • TMDX $133.54
  • SPR $41.39
  • Average True Range (ATR)
  • TMDX 6.78
  • SPR 0.78
  • MACD
  • TMDX 0.98
  • SPR -0.03
  • Stochastic Oscillator
  • TMDX 51.17
  • SPR 45.00

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About SPR Spirit Aerosystems Holdings Inc.

Spirit AeroSystems manufactures aerostructures, particularly fuselages, cockpits, wing sections, engine pylons, and nacelles for commercial and military aircraft. The company was spun out of Boeing in 2005 to become the largest independent supplier of aerostructures for commercial aircraft. Boeing and Airbus are the firm's primary customers—Boeing represented roughly 60% and Airbus roughly 20% of revenue in recent years. The company is highly exposed to Boeing's beleaguered 737 program, which accounts for nearly half the company's revenue. The company plans to be acquired by and reintegrated into Boeing in mid-2025.

Share on Social Networks: